Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

BioAscent

publication date: Jul 15, 2016
 | 
author/source: BioAscent Discovery

BioAscent Discovery, has launched Compound Cloud, a unique new service for early-stage drug discovery, providing rapid online access to a diverse collection of IP-free, high-quality chemicals for screening.

Compound CloudThe service applies the cloud-computing concept to drug discovery by enabling scientists to remotely pick and choose specific compounds of interest from over 125,000 stored at BioAscent’s state-of-the-art facility - as well as an increasing number of third party collections - and have them quickly prepared and delivered in the format and volume selected. Alternatively users can order convenient, pre-plated sets that contain the specific quantity needed for the current project, minimising costs. Either option saves organisations from having to purchase and maintain large collections at significant expense. By enabling chemists to pre-select structures to fit their exact needs and avoid compounds with undesirable characteristics, Compound Cloud can significantly reduce the likelihood of initial hits being rejected later on. 

Organisations expend considerable resources in developing or acquiring compound collections, often leading to significant wastage, both in terms of cost and time. BioAscent’s Compound Cloud offers options either for total flexibility in compound selection or for highly cost-efficient screening – both with rapid delivery times. Researchers who want complete control over the content and format of a library, can cherry-pick specific compounds from the collection and specify the exact format and layout of the plates. Alternatively, researchers can benefit from the convenience and lower cost of accessing Compound Cloud’s single-use, pre-plated compound sets. They can then return to the whole collection to create a hit-focused library, enabling the screening of a large chemical space using only a few assay wells. This is particularly useful when the assay is expensive or the reagents are difficult to make, thereby increasing the chances of identifying hits at lower cost.

“We’re really excited about the launch of Compound Cloud - it is truly an innovation that gives scientists more control for greater success”, explains Dr Simon MacKenzie, CEO of BioAscent. “The freedom to browse online and pick and choose compounds from our large collections to match the needs of any project, or alternatively access smaller, pre-plated sets at low cost,  is a huge step forward for early-stage drug discovery. We also despatch the orders very quickly – so there are no hold-ups -  which helps scientists find valuable leads much quicker and with much less effort and extremely cost-effectively. Compound Cloud brings the online ethos to drug discovery, enabling both companies and academic groups the freedom to build and use the best set of compounds for their specific projects.”


more about bioascent discovery


 

 



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events